Health tech manufacturer Phillips-Medisize has announced the opening of a global innovation and development centre in Copenhagen, Denmark to support its long-term growth plans for advanced injection, wearable devices and connected technologies.
The Molex company says it plans for the centre, based in the Teknikerbyen area, to help accelerate the creation of differentiated drug delivery devices for its global customer base, while providing an easily accessible hub for its European customers.
A leadership team is in place at the new office and recruitment efforts are underway to hire talent with pharma and medical device expertise in project management, quality assurance, regulatory affairs and engineering development across mechanical, software and electronics. The first hiring phase will include 30 employees, expandable to a 100-person workforce.
WHY IT MATTERS
The company said in a press release, that its increased focus on healthcare innovation in Europe and investment in hiring top talent demonstrates its “commitment to helping customers develop more intelligent drug delivery and connected health solutions that address patient needs.”
It believes that Copenhagen will offer an optimal location to access top drug delivery and connectivity resources that complement its existing European centres in Struer, Denmark and Cambridge, UK.
By establishing a presence in Copenhagen, Phillips-Medisize is in the middle of the Medicon Valley cluster, a leading international life sciences cluster, spanning eastern Denmark and southern Sweden.
As well as being close to top universities, hospitals and global R&D-based pharmaceutical and medical device companies, the company said it chose the region because it is “home to innovators exploring large unmet medical needs in areas such as oncology, diabetes and personalised medicine.”
THE LARGER CONTEXT
Phillips-Medisize, LLC, is an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical, diagnostics, and medical device market segments.
Currently, it operates innovation and development sites in Europe, North American and Asia, most recently Bangalore, India.
ON THE RECORD
Matt Jennings, CEO and president of Phillips-Medisize, said: “The opening of our new Copenhagen GID centre represents an exciting opportunity to expand our global footprint by supporting overall growth with closer proximity to current European clients, fortifying our business development efforts and attracting top talent in the region to join our growing team.”
